The Centers for Medicare & Medicaid Services (CMS) recently orchestrated a $5 billion election-year rescue operation for Democrats to hide the true costs of the Biden-Harris administration's Inflation ...
The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...
Our Health Care Group reviews a new five-year CMS demonstration project requiring ambulatory surgical centers (ASCs) in 10 states to obtain approval before performing certain procedures. The ...
On June 11, 2026, CMS issued new guidance that will change how states obtain and maintain approval for Section 1115 Medicaid Demonstration ...
CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results